Earnings Outlook For Kiniksa Pharmaceuticals
Portfolio Pulse from Benzinga Insights
Kiniksa Pharmaceuticals (NASDAQ:KNSA) is set to release its latest quarterly earnings report on Tuesday, 2023-07-25. Analysts estimate an earnings per share (EPS) of $-0.17. The company's past performance shows a pattern of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $15.59 and has seen a 36.88% increase over the last 52-week period.
July 24, 2023 | 8:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Kiniksa Pharmaceuticals is expected to release its Q2 earnings report. The company has a history of beating EPS estimates, which could potentially lead to a share price increase.
The company has a history of beating EPS estimates, which has often led to an increase in share price. Given this pattern and the positive 52-week performance, the upcoming earnings release could potentially have a positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100